Mack Gill

John M.
Gill was the founder of TetraLogic Pharmaceuticals Corp., founded in 2001, where the title held was Director from 2013 to 2014.
Current jobs include Independent Director at Altimmune, Inc. since 2004 and Chief Operating Officer at Torstone Technology Ltd. Former jobs include President, Chief Executive Officer & Director at PharmAthene, Inc. from 2015 to 2017; Chief Executive Officer at Millennium Information Technologies Ltd. from 2013 to 2026; Chief Financial Officer, Director & Executive VP at 3-Dimensional Pharmaceuticals, Inc.; Director at PharmAthene, Inc. in 2007; Director at Theraclone Sciences, Inc.; Director at The Biotechnology Greenhouse Corp.
of Southeastern PA; Director at Ben Franklin Technology Partners; SVP-Corporate Development & Strategy at FIS Capital Markets US LLC (Pennsylvania); President at GSK Equity Investments Ltd.; Principal at US Department of Defense (District of Columbia) from 1971 to 1973; Chief Operating Officer at Smithkline & French Laboratories US, Inc.; President-Global Technology at SunGard Financial Systems; Chief Operating Officer at Nova Pharmaceutical Corp.; VP-Research & Development Operations at GlaxoSmithKline LLC; and President at Sungard Global Services France SA from 2011 to 2011.
Education includes undergraduate degree from Rutgers State University of New Jersey in 1975, graduate degree from Yale University, and undergraduate degree from the University of British Columbia.